Exploration of the pathogenesis and treatment of pulmonary interstitial fibrosis secondary to systemic sclerosis based on the theory of sanjiao membranous channels
Thought and Method|更新时间:2025-12-04
|
Exploration of the pathogenesis and treatment of pulmonary interstitial fibrosis secondary to systemic sclerosis based on the theory of sanjiao membranous channels
“In the field of autoimmune diseases caused by rheumatism, experts have delved into the pathogenesis and treatment strategies of pulmonary interstitial fibrosis secondary to systemic sclerosis based on the theory of trifocal conduit, providing new ideas for patients' overall state adjustment.”
Journal of Beijing University of Traditional Chinese MedicineVol. 48, Issue 5, Pages: 646-651(2025)
作者机构:
1.北京中医药大学研究生院 北京 100029
2.北京中医药大学东方医院
3.北京中医药大学东直门医院
作者简介:
Prof. ZHANG Xiaomei, Ph. D., Chief Physician, Doctoral Supervisor. Dongfang Hospital, Beijing University of Chinese Medicine, No.6, Zone 1, Fangxingyuan, Fengtai District, Beijing 100078. E-mail: Zhangxim6767@sina.com
基金信息:
Scientific Research Project of Capital Health Development(2020-2-4202)
SUN Yunlong, ZHANG Xiaomei, YANG Tianshu, et al. Exploration of the pathogenesis and treatment of pulmonary interstitial fibrosis secondary to systemic sclerosis based on the theory of sanjiao membranous channels[J]. Journal of Beijing University of Traditional Chinese Medicine, 2025, 48(5): 646-651.
DOI:
SUN Yunlong, ZHANG Xiaomei, YANG Tianshu, et al. Exploration of the pathogenesis and treatment of pulmonary interstitial fibrosis secondary to systemic sclerosis based on the theory of sanjiao membranous channels[J]. Journal of Beijing University of Traditional Chinese Medicine, 2025, 48(5): 646-651. DOI: 10.3969/j.issn.1006-2157.2025.05.007.
Exploration of the pathogenesis and treatment of pulmonary interstitial fibrosis secondary to systemic sclerosis based on the theory of sanjiao membranous channels